Ascendis Pharma A/S (ASND): Price and Financial Metrics


Ascendis Pharma A/S (ASND)

Today's Latest Price: $155.72 USD

3.17 (-2.00%)

Updated Jan 26 6:55pm

Add ASND to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 484 in Biotech

See all "A" rated Strong Buy stocks

ASND Stock Summary

  • Ascendis Pharma A's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 9.35% of US listed stocks.
  • With a price/sales ratio of 720.37, Ascendis Pharma A has a higher such ratio than 98.98% of stocks in our set.
  • Revenue growth over the past 12 months for Ascendis Pharma A comes in at -56.01%, a number that bests merely 4.17% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to ASND, based on their financial statements, market capitalization, and price volatility, are KLDO, OTIC, PRTA, MRTX, and SNDX.
  • Visit ASND's SEC page to see the company's official filings. To visit the company's web site, go to www.ascendispharma.com.

ASND Stock Price Chart Interactive Chart >

Price chart for ASND

ASND Price/Volume Stats

Current price $155.72 52-week high $183.98
Prev. close $158.89 52-week low $92.00
Day low $153.72 Volume 329,300
Day high $161.00 Avg. volume 156,375
50-day MA $166.77 Dividend yield N/A
200-day MA $151.10 Market Cap 8.32B

Ascendis Pharma A/S (ASND) Company Bio


Ascendis Pharma A/S is applying its innovative TransCon technology, which combines the benefits of prodrug and sustained release technologies, to develop a pipeline of best-in-class therapeutics that address significant unmet medical needs. The company was founded in 2006 and is based in Hellerup, Denmark.


ASND Latest News Stream


Event/Time News Detail
Loading, please wait...

ASND Latest Social Stream


Loading social stream, please wait...

View Full ASND Social Stream

Latest ASND News From Around the Web

Below are the latest news stories about Ascendis Pharma A that investors may wish to consider to help them evaluate ASND as an investment opportunity.

Ascendis Pharma (ASND) Presents At 39th Annual J.P. Morgan Healthcare Conference - Slideshow

The following slide deck was published by Ascendis Pharma A/S in conjunction with this event....

SA Transcripts on Seeking Alpha | January 20, 2021

New Strong Sell Stocks for January 14th

Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today.

Yahoo | January 14, 2021

New Strong Sell Stocks for January 13th

Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today.

Yahoo | January 13, 2021

Sequoia China Leads $150 Million Round In Drug Developer Visen Pharma

Chinese new endocrine drug developer Visen Pharma announced the completion of US$150 million in Series B financing, led by Sequoia China Fund. Aobo Capital, Sherpa Investment, Cormorant, HBM Healthcare Investments, Dingfeng Biotech Capital, Logos Capital, Chenling Capital also participated in the investment. Existing shareholders Ascendis Pharma A/S, Vivo Capital, Sofinnova Investments continued to invest in […] Sequoia China Leads $150 Million Round In Drug Developer Visen Pharma comes from China Money Network : Primary Data for China's Primary Markets! All Rights Reserved.

China Money Network | January 12, 2021

Ascendis Pharma provides 2021 updates at annual Healthcare Conference

Ascendis Pharma A/S (ASND) +4% expects to achieve number of key clinical and commercial milestones in 2021. By the end of 2021, the company expect to have five independent TransCon product candidates in clinical development leveraging TransCon technologies through our algorithm for product innovation.TransCon hGH (Lonapegsomatropin): Lonapegsomatropin is an investigational long-acting prodrug...

Seeking Alpha | January 11, 2021

Read More 'ASND' Stories Here

ASND Price Returns

1-mo -8.30%
3-mo -5.05%
6-mo 13.16%
1-year 14.52%
3-year 190.31%
5-year 717.86%
YTD -6.63%
2020 19.88%
2019 122.06%
2018 56.39%
2017 97.92%
2016 10.48%

Continue Researching ASND

Want to see what other sources are saying about Ascendis Pharma A's financials and stock price? Try the links below:

Ascendis Pharma A (ASND) Stock Price | Nasdaq
Ascendis Pharma A (ASND) Stock Quote, History and News - Yahoo Finance
Ascendis Pharma A (ASND) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8406 seconds.